Targeting esophageal cancer with HDL nanoparticles: an imaging study<br> - TARGET

Academisch Medisch Centrum0 个研究点目标入组 9 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•- Adult patients (either gender) older than 18 years
•- Clinical diagnosis of primary esophageal cancer

•A potential subject who meets any of the following criteria will be excluded from participation in this study:
•- Any treatment that could interfere with the conduct or interpretation of the study in the opinion of the investigator
•- Any clinically relevant condition that could interfere with the conduct of the study in the opinion of the investigator
•- Standard contra-indications to PET, CT or MRI
•- Inability or unwilling to comply with protocol requirements, or deemed by the investigator to have a disorder that may compromise the ability to give informed consent and/or to comply with all required study procedures and visits

发起方